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Plus-strand DNA synthesises multiple spliced RNAs that can be reverse transcribed into viral DNA. We
thoroughly characterized the contribution of spliced RNAs to DNA synthesis in transfected cultures of Huh7
and HepG2 cells. We found that up to 50% of DNA within intracellular capsids is derived from ﬁve spliced
RNAs. Expressing HBV P protein and pgRNA from separate plasmids and the use of the CMV-IE promoter
contributes to these high levels of encapsidated DNA derived from spliced RNA. A spliced RNA called Sp1 was
the predominant species expressed in both cell lines. All spliced RNAs support the synthesis minus-strand
DNA and duplex linear DNA. Only one of the spliced RNAs, Sp14, supported the synthesis of relaxed circular
DNA because splicing removed an important cis-acting sequence (hM) in the other four RNAs. Additionally,
we created a variant that was deﬁcient in the synthesis of spliced RNA and supported DNA synthesis at wild-
type levels. Our results reinforce and extend the idea that a signiﬁcant fraction of HBV DNA synthesized
under common experimental conditions is derived from spliced RNA. It is important that their presence be
considered when analyzing HBV DNA replication in transfected cell cultures.
© 2008 Elsevier Inc. All rights reserved.IntroductionHepatitis B virus (HBV), a member of the Hepadnaviridae family,
causes both acute and chronic infections of the liver. Chronically
infected individuals have an increased risk of developing severe liver
diseases such as cirrhosis and hepatocellular carcinoma (Beasley,
1988). Maintenance of a chronic state requires the 3.2 kb genome to
be maintained in the nucleus of the hepatocyte as double-stranded,
covalently closed circular (ccc) DNA (Tuttleman et al., 1986). Host
RNA polymerase II transcribes all viral RNAs from cccDNA, which are
classiﬁed as either unspliced or spliced. The unspliced RNAs consist
of the pregenomic (pg) RNA, the precore mRNA and the subgenomic
(sg) RNAs. These RNAs are transcribed from different promoters and
hence have different 5′ ends but share a common 3′ end. The pgRNA,
which is 3.5 kb, is the mRNA for the core (C) and the polymerase (P)
proteins. The precore RNA is the mRNA for HBeAg, a secreted protein
(Ou et al., 1986). The sgRNAs comprise a set of 2.4 kb, 2.1 kb and 0.9
kb RNAs. The L protein is translated from the 2.4 kb RNA, whereas
the M and S proteins are translated from two different 2.1 kb RNAs.
The X protein is translated from the 0.9-kb mRNA. The pgRNA is the
only unspliced RNA that is encapsidated into core particles and
reverse transcribed into DNA (Nassal et al., 1990; Summers and
Mason, 1982)..
l rights reserved.When we performed Southern blotting on intracellular capsids
from transfected cultures of Huh7 or HepG2 cells, a more complicated
proﬁle was seen when compared to duck hepatitis B virus (DHBV)
(Fig. 1A). For DHBV most, if not all, encapsidated replicative inter-
mediates are derived only from the pgRNA. For HBV, this is not the
case. Several DNA species migrating faster than single-stranded (SS)
DNA were seen when native or denatured HBV replicative inter-
mediates were analyzed by Southern blotting (Fig. 1A, right panel).
We undertook this study to characterize this complex proﬁle of
replicative intermediates seen during HBV replication in our cell
cultures.
For HBV, in addition to pgRNA, several spliced RNA transcripts are
also encapsidated and reverse transcribed into DNA. To date, at least
12 spliced RNA transcripts derived from the same promoter as pgRNA
have been described (Gunther et al., 1997; Rosmorduc et al., 1995;
Sommer et al., 2000; Su et al., 1989a; Suzuki et al., 1990; Suzuki et al.,
1989; Terre et al., 1991; Wu et al., 1991). These spliced RNA trans-
cripts contain the encapsidation signal, ε, and have different introns
removed. The presence of the encapsidation signal in the spliced
RNA transcripts permits the packaging of these RNAs into capsids
when C and P proteins are present. One transcript, called Sp1 (as
classiﬁed by Gunther et al., 1997), is the major spliced RNA in multiple
reports. Sp1 RNA has a 1.0 kb intron from nt 2446 to 486 (inclusive).
Sp1 RNA has the potential to encode core protein with the ter-
minal cysteine residue deleted; it does not encode functional P and
envelope proteins (Gunther et al., 1997; Su et al., 1989a). Sp1 RNA
and DNA reverse transcribed from Sp1 RNA have been detected in
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fected cell cultures (Su et al., 1989a; Su et al.,b; Terre et al., 1991; Wu
et al., 1991).Fig. 1. The proﬁle of HBV replicative intermediates isolated from cytoplasmic capsids is
more complex than those of DHBV. (A) Southern blot of replicative intermediates
isolated from cytoplasmic capsids of HBV and DHBV. Left panel represents DHBV
replicative intermediates isolated from LMH cells transfected with plasmid D1.5G. Right
panel represents HBV replicative intermediates isolated from Huh7 cells co-transfected
with plasmids NL84 and LJ96. Samples were either untreated (native) or heat denatured
before electrophoresis. Relaxed circular (RC), duplex linear (DL) and single-stranded
(SS) DNA species are indicated. The blots were hybridized with a full-length, minus-
strand-speciﬁc riboprobe for either DHBV or HBV. The black dots to the left of the blot
indicate the location of RC, DL and SS DNA. (B) Southern blot of HBV replicative
intermediates isolated from intracellular capsids from cultures of HepG2 or Huh7 cells
co-transfected with plasmids NL84 and LJ96. Top panels have been hybridized with a
minus-strand-speciﬁc oligonucleotide complementary to the 5′ end (ayw1661+) or 3′
end (ayw 1995+) of minus-strand DNA. Bottom panels have been hybridized with a plus-
strand-speciﬁc oligonucleotide complementary to the 5′ end (ayw1948−) or 3′ end
(ayw1530−) of plus-strand DNA. The black dots to the left of the blot indicate the
location of RC, DL and SS DNA.A common experimental method to study nucleic acid replication
of HBV is to transfect cultures of Huh7 or HepG2 cells with separate
plasmids that express the replication proteins (C and P) or the
replication template (pgRNA). Under these conditions, both pgRNA
and spliced RNAs will be expressed, encapsidated and reverse trans-
cribed into DNA. If spliced RNA differs from pgRNA in its ability to be
reverse transcribed into minus-strand and plus-strand DNA, then
our ability to elucidate the contributions of cis-acting sequences and
trans-acting factors to the replication of pgRNA will be impacted. To
this end, we identiﬁed and quantitated the level of spliced RNA and
DNA derived from these RNAsmade in our cell cultures. Also, wemade
recombinant plasmids that expressed each of the spliced RNAs indi-
vidually when transfected into cell cultures and characterized their
ability to support the synthesis of minus-strand and plus-strand DNA.
Finally, we created a variant that made undetectable levels of spliced
RNA. This variant synthesized normal levels of minus-strand and plus-
strand DNA.
Results
Proﬁle of HBV replicative intermediates isolated from cytoplasmic
capsids is more complex than those of DHBV
Southern blot analysis of native replicative intermediates of DHBV
isolated from transfected LMH cells shows a characteristic pattern that
is comprised of three major forms, RC, DL and SS DNA. Each of these
three intermediates contains a full-length (FL) minus-strand DNA.
Upon heat denaturation of replicative intermediates, Southern blot
analysis showed a single band that corresponds to FL minus-strand
DNA (Fig. 1A, left panel). In contrast, native and denatured DNA
isolated from intracellular HBV capsids from cultures of transfected
Huh7 cells showed a complex pattern (Fig. 1A, right panel), with
several unidentiﬁed DNA species in addition to FL DNA. To understand
and characterize these unidentiﬁed bands, end-labeled oligonucleo-
tide ayw1661+ and ayw1995+ were used as hybridization probes to
detect the sequences at the 5′ and 3′ ends, respectively, of minus-
strand DNA (Fig. 1B, top panels). This result indicated that the DNA
species had the 5′ and 3′ ends found in FL minus-strand DNA,
suggesting that they were neither a result of incomplete elongation of
minus-strand DNA nor the result of use of an internal acceptor site
during the template switch during minus-strand DNA synthesis.
Southern blot analysis with oligonucleotides ayw1948− and
ayw1530−, which hybridize close to the 5′ and 3′ ends of plus-strand
DNA, respectively, detected fewer discrete bands (Fig. 1B, bottom
panels). The majority of DNA detected corresponds to the full-length
plus-strand of RC and DL DNA. In Huh7 and HepG2 cells, plus-strand
DNA that migrated faster than FL plus-strand DNA was detected with
both the 5′ and 3′ end probes (Fig. 1B, bottom right panels).
Identiﬁcation of different DNA species from intracellular capsids
To identify the species that migrated faster than FL minus-strand
DNA, we isolated intracellular replicative intermediates from Huh7
and HepG2 cells transfected with plasmids NL84 and LJ96, and
performed PCR using oligonucleotides ayw1816+ and ayw1821−. These
PCR products were cloned into the HindIII (nt 1910) and BmgBI
(nt 1600) restriction sites of plasmid NL84 (see Materials and
methods and Table 2 for description of plasmids).
We recovered ﬁve different plasmids that were missing different
portions of the HBV genome (Fig. 2). The deleted sequences cor-
responded precisely to introns previously seen in spliced RNAs or the
DNAs derived from spliced RNA (Gunther et al., 1997; Su et al., 1989a;
Suzuki et al., 1990). Sp1, 3, 6 and 14 all have a single intron removed.
Sp18 removes two previously-described introns in a combination not
reported to date. All ﬁve species use the splice acceptor site at nt 485.
We did not recover any recombinant plasmids containing the
Fig. 2. Five species of DNA derived from spliced RNAwere detected in replicative intermediates from intracellular capsids. (A) Schematic representation of pgRNA. The locations of the
C and P genes are indicated. The white vertical boxes represent the direct repeat (DR) sequences, DR1: nts 1822–1832 and DR2: nts 1588–1598. The 5′ end of pgRNA is nt 1816. The
poly(A) tail begins at approximately nt 1930. The deletions generated by splicing are indicated by thin black lines. The nucleotide coordinates of the deleted sequences are inclusive.
(B) Southern blot of denatured HBV replicative intermediates isolated from intracellular capsids from Huh7 cells transfected with plasmids NL84 and LJ96. The membrane was
hybridized sequentially with minus-strand-speciﬁc oligonucleotides that anneal to the 3′ end of all minus-strand DNAs and to the splice junctions of the various spliced RNAs. To
detect all minus-strand DNA, oligonucleotides ayw1995+; Sp1, 2445/487+; Sp3, 2066/487+; Sp6, 2469/487+; Sp14 and 18, 2983/487+, were used. Linearized plasmids were used as
markers for size, speciﬁcity, efﬁciency of probing and asmass standards. Each spliced formwas expressed as a percent of total minus-strand DNA for both Huh7 and HepG2 cells. Total
minus-strand DNA is the measurement of all species between, and including, full-length (FL) and Sp3 minus-strand DNA. The positions of FL minus-strand DNA, Sp1, 3, 6, 14 and 18
minus-strand DNA are indicated. Percent minus-strand DNA for Sp6 and Sp18 in HepG2 cells were not determined.
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1997 for a comprehensive description of spliced donor and acceptor
sequences used by HBV).
To measure the levels of each species of DNA derived from
spliced RNA we used oligonucleotides that annealed to the individual
splice junctions as hybridization probes. Fig. 2 shows a representative
Southern blot. Oligonucleotide ayw1995+ detects all minus-strand
DNA that have elongated to nt 1995 (Fig. 2). Oligonucleotides Sp1, 3, 6,
and 14/18 will anneal to each of the respective splice junctions (see
Table 1 for nucleotide sequence). Plasmids NL84, Sp1, 3, 6, 14 and 18
were digested with restriction enzyme Psi I, which results in double-Table 1
Oligonucleotides used as hybridization probes to detect minus-strand or plus-strand
DNA in Southern and northern blotting analyses
Name Detects Sequence
ayw1661+a 5′ end (−) CTCTTGGACTCTCAGCAATGTCAAC
ayw1995+a 3′ end (−) ACCGCCTCAGCTCTGTATCG
Sp1: 2445/487+b Sp1 (−) GGGAATCTCAAT/GATCCTCAACAA
Sp3: 2065/487+b Sp3 (−) ACTGCACTCAG/GATCCTCAAC
Sp6: 2469/487+b Sp6 (−) TGGACTCATAAG/GATCCTCAAC
Sp14/18: 2983/487+b Sp14 and Sp18 (−) GCCAACAAG/GATCCTCAAC
ayw1948−c 5′ end (+) GAGAGTAACTCCACAGTAGCTCC
ayw1530−d 3′ end (+) GAGGTGCGCCCCGTGGTCGGTCG
ayw2007−c 5′ end (+) GAGCTGAGGCGGTATCTAGAA
a Detects 5′ or 3′ end of full-length and all splice-derived minus-strand DNA.
b The coordinates indicate the nucleotide position of each splice junction. Backslash
(/) indicates the splice junction for probes used to detect speciﬁc splice-derived (−) DNA.
c Detects pgRNA, spliced RNA, and the 5′ end of full-length and all splice-derived
plus-strand DNA.
d Detects the 3′ end of plus-strand DNA derived from pgRNA and spliced RNA.stranded linear DNA of 3182 bp, 1959 bp, 1579 bp, 1983 bp, 2497 bp
and 2067 bp, respectively. These linearized plasmids were used as
markers for size, speciﬁcity of hybridization, and to normalize for
efﬁciency of hybridization. Using the linearized plasmids as mass
standards, we determined the proportion of each DNA derived from
spliced RNA compared to total minus-strand DNA.
From this analysis, we found that Sp1 was the predominant DNA
derived from spliced RNA within intracellular capsids in our cell
cultures. Sp1 DNA represented 25% and 20% of total minus-strand DNA
in our cultures of Huh7 and HepG2 cells, respectively. FL minus-strand
DNA represented 35% and 45% of total minus-strand DNA in Huh7 and
HepG2 cell cultures, respectively. Sp14 constitutes approximately 10%
of total minus-strand DNA in both cell lines. Sp3 represents 5% and
10% of total minus-strand DNA in HepG2 and Huh7 cells, respectively.
Using this approach, we accounted for approximately 80% of minus-
strand DNA within capsids.
Expressing pgRNA and the replication proteins from separate plasmids
lead to an increase in DNA derived from spliced RNA
To determine whether the levels of DNA derived from spliced RNA
were inﬂuenced by the design of our experiments, we examined two
parameters. First, we examined our strategy of providing the repli-
cation proteins and pgRNA from separate plasmids (NL84 + LJ96; see
Table 2 for description) to engender replication. Normally, P protein
preferentially encapsidates the pgRNA from which it is translated
(Bartenschlager et al., 1990). In our system pgRNA transcribed from
plasmid NL84 is not the mRNA for the replication proteins, P and C,
due to premature stop codons in those genes (Liu et al., 2004). These
Table 2
HBV expressions plasmids, pgRNA promoter, and genotype
Plasmid name pgRNA promoter Genotypea
NL84 CMV IE ε+C−P−S−X−
EL49 CMV IE ε+C−P−S−X−Spl−
LJ96 CMV IE ε−C+P+S−X+
LJ140 HBV ε+C+P+S−X+
LJ144 CMV IE ε+C+P+S−X+
a Status of genetic elements within each plasmid. + indicates functional, − indicates
inactivated by mutation. ε — RNA encapsidation signal, C — C gene, P — P gene, S —
envelope gene, X— X gene, and Spl−indicates mutation to inactivate splice acceptor site
at nt 487.
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which is not encapsidated, due to deletion of ε (Liu et al., 2004). To
determine whether the high levels of DNA derived from spliced RNA
were due to a loss of preferential encapsidation of the pgRNA, we
compared replication in cells transfected with NL84 and LJ96 (in trans)
to replication in cells where P and C proteins were translated from the
same pgRNA (in cis: LJ144).Fig. 3. The method to engender replication inﬂuences the levels of spliced RNA and
subsequent DNA synthesis. (A) Southern blot of replicative intermediates isolated from
intracellular capsids from Huh7 and HepG2 cells. Cells were transfected with either
plasmid LJ144 (cis) or plasmids NL84 and LJ96 (trans). The CMV-IE promoter drives RNA
transcription from plasmids LJ144, NL84 and LJ96. The two lanes represent duplicate
samples. An oligonucleotide (ayw1995+) complementary to the 3′ end of minus-strand
DNA was used as a hybridization probe. The positions of FL minus-strand DNA and Sp1
minus-strand DNA are indicated. The ratio of Sp1 to FL minus-strand DNA is indicated
below the Southern blots. FL, full-length. (B) Northern blot of total cellular, poly(A)-
selected RNA isolated from Huh7 and HepG2 cells. Cells were transfected with either
LJ144 or LJ140 plasmids. The CMV-IE promoter drives transcription from plasmid LJ144.
Endogenous HBV promoter drives transcription from plasmid LJ140. One-third (LJ140)
or 1/10 (LJ144) of the RNA isolated from a 60mm plate was analyzed by northern
blotting. An oligonucleotide (ayw2007−) complementary to the 5′ end of pgRNA and
spliced RNAs was used as hybridization probe. The pgRNA and Sp1 RNA are indicated.
The ratio of Sp1 RNA to pgRNA is indicated below the northern blots.DNAwas isolated from intracellular capsids from HepG2 and Huh7
cells and Southern blotting was performed on denatured replicative
intermediates. The membrane was hybridized with oligonucleotide
ayw1995+, which detectsminus-strand DNA derived from both spliced
RNA and pgRNA (Fig. 3A). We compared the ratio of Sp1 DNA to FL
DNA. In both HepG2 and Huh7 cells, the proportion of DNA derived
from spliced RNA increased 2- to 3-fold when the replication proteins
were provided in trans. This increase in the ratio of Sp1 to FL minus-
strand DNA cannot be attributed to an increase in the level of Sp1 RNA.
Total poly(A)-selected RNA from cell cultures transfected with
plasmids LJ144 or NL84 showed that the ratios of Sp1 RNA to pgRNA
were similar (data not shown).
CMV-IE promoter increases the proportion of spliced RNA
Next, we examined whether the promoter used to drive transcrip-
tion of the pgRNA and spliced RNA inﬂuenced their proportions. The
CMV-IE promoter is widely used to express pgRNA because it leads to
higher levels of pgRNA than the endogenous HBV promoter in cell
cultures. A recent study observed an increase in levels of splicing of
retroviral RNAwhen transcriptionwas under the control of the CMV-IE
promoter instead of the retroviral long terminal repeat (LTR) (Bohne et
al., 2007). To test whether the use of the CMV-IE promoter enhances
accumulation of spliced RNA, we compared levels of Sp1 RNA to pgRNA
from cells transfected with plasmids LJ140 (HBV promoter) or LJ144
(CMV promoter). Total poly(A)-selected RNA was isolated from Huh7
and HepG2 cells and Northern blotting was performed. The membrane
was hybridized with oligonucleotide ayw2007−, which detects a
sequence close to the 5′ end of pgRNA and spliced RNA. This probe
does not detect sgRNA. In cultures of Huh7 cells the ratio of Sp1 RNA to
pgRNA increased approximately two-fold (Fig. 3B). In HepG2 cell
cultures the increase in splicingwasmodest, but statistically signiﬁcant.
Taken together, our results indicate that the relative level of DNA
derived from spliced RNA is dependent on at least two factors: the
promoter used to drive transcription of pgRNA and whether P protein
is provided in cis or in trans. Although Huh7 and HepG2 cells display
similar trends, HepG2 cells appear to produce a higher proportion of
spliced RNA to pgRNA than Huh7 cells (Fig. 3B). Conversely, DNA
derived from spliced RNA is more abundant in Huh7 cells as compared
to HepG2 cells (Fig. 3A).
All spliced RNAs give rise to DL DNA; only Sp14 RNA can be reverse
transcribed into RC DNA
The presence of DNA derived from spliced RNAs can complicate the
study of DNA synthesis. For example, if the spliced RNAs were not
efﬁciently converted into RC DNA, then their presence could com-
plicate studies of RC DNA synthesis. To understand whether spliced
RNAs were converted into minus-strand and plus-strand DNA asTable 3
Efﬁciency of minus-strand and plus-strand DNA synthesis of HBV DNA in Huh7 cells
relative to NL84 (WT=100)
(−) DNA
synthesisa
Priming from
DR2b
Circularizationb Priming from
DR1b
Total
primingb
NL84 (WT) 100 100 100 100 100
EL49 (Sp−) 102±1 127±8 116±3 80±3 106±5
Sp1 98±4 25±4 NDc 135±34 75±12
Sp3 88±5 25±10 ND 116±26 68±15
Sp6 104±8 23±5 ND 138±42 76±17
Sp14 116±4 117±19 117±28 127±7 123±11
Sp18 110±12 25±6 ND 152±48 83±19
a Measured by primer extension with two oligonucleotides as described previously
(Abraham and Loeb, 2006).
b Measured by primer extension with one oligonucleotide as described previously
(Lewellyn and Loeb, 2007; Haines and Loeb, 2007).
c ND—none detected.
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spliced forms and analyzed their ability to support the synthesis of
DNA in cell culture. To analyze the ability of the spliced RNAs to be
converted into minus-strand DNA, encapsidated replicative inter-
mediates were isolated and primer extension was performed to
measure the level of minus-strand DNA as a function of encapsidated
pgRNA (Table 3) (Abraham and Loeb, 2006). To measure the level of
priming of plus-strand DNA from DR2 and DR1, primer extension was
performed (Fig. 4B), as described (Lewellyn and Loeb, 2007). Table 3
summarizes the ability of each of the spliced RNAs to support the
synthesis of minus- and plus-strand DNA.
We learned that once a spliced RNA is packaged into a capsid it is
reverse transcribed into minus-strand DNA as efﬁciently as the WT
reference (Table 3). Based on Southern blotting, we determined thatalthough all spliced formswere converted into DL DNA, only Sp14 RNA
was converted into RC DNA (Fig. 4A). Synthesis of the plus-strand of
RC DNA requires two template switches, primer translocation and
circularization (Lien et al., 1986). Both primer translocation and circu-
larization are a result of priming from DR2. Using primer extension to
analyze Sp14, we learned that the levels of priming from DR2 (DR2:
pre-circ) and circularization (DR2: post-circ) were at the same level as
the WT reference (Fig. 4B). In contrast, priming from DR2 for Sp1, 3, 6
and 18 was at 25% the level of the WT reference (Table 3 and Fig. 4B,
DR2: pre-circ), and no circularizationwas detected (Fig. 4B, DR2: post-
circ). All spliced forms displayed higher than WT levels of priming
from DR1 (Fig. 4B, DR1: in situ).
Mutation of the splice acceptor site abrogates splicing
To simplify our analyses, we sought to remove these spliced RNAs
from our cell cultures. We changed four nucleotides within the splice
acceptor site at nt 485 (plasmid EL49) (Fig. 5A). Northern blotting of
total poly(A)-selected RNA showed that EL49 did not express
detectable levels of Sp1 RNA. Southern blotting of replicative inter-
mediates from intracellular capsids showed that DNA derived from
Sp1, Sp3, Sp6, Sp14, and Sp18 RNA was not detected (Fig. 5B and data
not shown) although there were still several faster-migrating DNA
species present at low levels. The identity of these DNA forms is
presently unknown. The mutation in EL49 did not affect minus- and
plus-strand DNA synthesis (Table 3).
Discussion
This study reveals that the gamut of HBV replicative intermediates
is not as simple as that for DHBV, where RC, DL and SS DNA inter-
mediates are derived from a single template, pgRNA (Fig. 1A). In our
cell cultures, in addition to the canonical RC, DL, and SS DNA, HBV
synthesizes multiple additional species of DNA (Fig. 1A). We
demonstrate that most of these DNA species arise from reverse trans-
cription of spliced RNA. These spliced RNA transcripts are encap-
sidated and reverse transcribed into minus-strand DNA. All spliced
forms are converted into DL DNA, but only Sp14 RNA is converted into
RC DNA. The presence of these spliced forms of DNA can complicate
the study of HBV DNA synthesis if not recognized and taken into
account. In the reported literature it is not uncommon for us to see
misidentiﬁcation the DNA forms in Southern blot analysis of intra-
cellular capsid DNA. Usually this entails identifying the major spliced
species as SS DNA and authentic SS DNA as DL DNA. An unrecognized
misidentiﬁcation like this would indicate higher levels of DL than RC
DNA, a situation that is implausible, if not impossible, for WT HBV.Fig. 4. All spliced RNAs support the synthesis of DL DNA, only Sp14 RNA engenders the
synthesis of RC DNA. (A) Southern blot of replicative intermediates from intracellular
capsids isolated from Huh7 cells transfected with either pgRNA expression plasmid
(NL84) or each of the spliced RNA expression plasmids and the donor plasmid (LJ96).
Panels containing either native or heat denatured samples are indicated. Markers for
duplex linear and single-stranded DNA are shown on the left and right, respectively. An
oligonucleotide (ayw 1995+) complementary to the 3′ end of minus-strand DNA was
used as hybridization probes. (B) Primer extension analysis with oligonucleotides 1661+
(top), 1815− (middle) and 1948− (bottom). Oligo 1661+ was used to measure the level of
minus-strand DNA and anneals 164 nt from the its 5′ end. Oligo 1815− was used to
measure the level of plus-strand priming from DR2 and anneals 217 nt from DR2 at a
position prior to the circularization point. Oligo 1948− was used to measure the level of
plus-strand priming from DR1 and the level of circularized plus-strands that initiated
from DR2. It anneals 116 nt from DR1 and 126 nt from the circularization point.
Sequencing ladder is on the right. Bands representing internal standard (IS), minus-
strand (−) DNA, priming from DR2:pre-circ, priming from DR2:post-circ and priming
from DR1:in situ are indicated on the left. The signal for each HBV-derived band was
normalized to the signal for its internal standard. The level of priming from DR2 was
calculated as the level of DR2:pre-circ divided by (−) DNA. Circularizationwas calculated
as the level of DR2:post-circ divided by DR2:pre-circ. Priming from DR1 was calculated
as the level of DR1:in situ divided by (−) DNA. Total priming was calculated as the sum of
priming from DR2: pre-circ plus priming from DR1. All values were expressed as a
percentage of a WT reference (NL84).
Fig. 5. Mutations in common splice acceptor site abrogates splicing. (A) Canonical
sequence for 3′ splice site is indicated in bold (CAGG) on plasmid NL84. The four-nt
substitution within the splice acceptor site in plasmid EL49 is indicated. (B) Left panel is
a northern blot of total cellular poly(A)-selected RNA from Huh7 cells transfected with
plasmids NL84 (Sp+) or EL49 (Sp−). Sp+ and Sp− indicate whether the splice acceptor site
is unaltered or mutated. The position of pgRNA and Sp1 RNA are indicated. The
membrane was hybridized with a plus-strand-speciﬁc oligonucleotide (ayw2007−)
complementary to the 5′ ends of pgRNA and all spliced RNAs. This probe does not detect
sgRNAs. The right panel is a Southern blot of DNA from Huh7 cells co-transfected with
plasmids NL84 or EL49 and donor plasmid, LJ96. The samples are either native or heat
denatured. The position of RC, DL and SS are indicated for native samples. The position
of FL minus-strand DNA and Sp1 minus-strand DNA is indicated for heat denatured
samples. The Southern blot was hybridized with an oligonucleotide (ayw1995+)
complementary to the 3′ end of minus-strand DNA. FL, full-length; RC, relaxed circular;
DL, duplex linear; SS, single-stranded.
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intracellular capsids using oligonucleotides speciﬁc for each splice
junction as hybridization probes in Southern blotting. We character-
ized ﬁve spliced RNA transcripts, Sp1, 3, 6, 14 and 18, that are
synthesized, encapsidated and reverse transcribed into DNA in our cell
cultures. Our study shows that for the ayw subtype (genotype D), Sp1
is the predominant DNA derived from spliced RNA detected within
intracellular capsids in both Huh7 and HepG2 cell cultures. Sommer et
al. (Sommer et al. (2000) also found that Sp1 was the major spliced
RNA transcribed in HepG2 and Huh7 cell cultures transfected with
HBV genotypes C, D and E.
We have shown that the high levels of DNA derived from spliced
RNA are in part due to the methods used to engender replication.
When the replication proteins were translated from an mRNA (LJ96)
other than the pgRNA, the ratio of DNA derived from spliced RNA to
DNA derived from pgRNA increased 2.4- and 3.5-fold in HepG2 and
Huh7 cells, respectively, as compared to when the replication proteins
were translated from the pgRNA (LJ144) (Fig. 3A). This increase in the
proportion of DNA derived from spliced RNA could be the result of
enhanced transcription/splicing, increases in encapsidation of spliced
RNA or the efﬁciency of minus-strand DNA synthesis. Analysis of total
poly(A)-selected RNA isolated from cell cultures transfected with
plasmids LJ144 or NL84 showed that the ratio of Sp1 RNA to pgRNA
was similar (data not shown). This result suggests that differential
transcription/splicing from plasmids LJ144 and NL84 does not
contribute to the increase in DNA derived from spliced RNA. Also,
each spliced RNA supports minus-strand DNA synthesis to the same
level as pgRNA (Table 3). Therefore, the increase in levels of DNA
derived from spliced RNA likely reﬂects a relative increase in
encapsidation of spliced RNA when replication proteins are provided
in trans (NL84 + LJ96).
We found that the promoter used to engender transcription of
pgRNA also inﬂuences the levels of spliced RNA in cell culture. There is
precedence for this ﬁnding. Several reports indicate that the choice ofpromoter affects levels of splicing by decreasing the rate of elongation
of the RNA polymerase II or by recruiting different splicing factors to
the RNA transcription complex (Auboeuf et al., 2002; Bohne et al.,
2007; Cramer et al., 1997; de la Mata et al., 2003). In Huh7 cells, a two-
fold increase in splicing was seen when the CMV-IE promoter was
used to engender transcription when compared to the endogenous
HBV promoter (Fig. 3B). In HepG2 cells, this increasewas 1.3-fold. Also,
the relative levels of splicing of HBV RNA differed in Huh7 and HepG2
cells. In HepG2 cells, there is a two-fold increase in spliced RNAs as
compared to Huh7 cells, independent of promoter (Fig. 3B). This
difference in the ratio of spliced RNA to pgRNA is likely a reﬂection of
differences in the synthesis or degradation of HBV RNA between the
two cell lines.
Whenwe analyzed cells transfectedwithplasmids that individually
expressed each spliced RNA transcript, we learned that all supported
the synthesis of minus-strand DNA as well as the wild-type reference
(Table 3). In addition, all spliced RNA transcripts supported the syn-
thesis of DL DNA (Fig. 4A). Only Sp14 RNA engendered the synthesis of
RC DNA (Fig. 4A). Primer extension analysis showed that Sp14
undergoes both primer translocation and circularization to the same
extent as the WT reference (Fig. 4B and Table 3). Sp1, 3, 6 and 18
undergo primer translocation at about 25% the level of the WT
reference with no detectable circularization. This result is expected
because the introns spliced from Sp1, 3, 6 and 18 RNA remove a re-
quired cis-acting sequence, hM, for the synthesis of RC DNA (Lewellyn
and Loeb, 2007). Although all spliced RNAs support slightly higher levels
of plus-strand priming from DR1 (approximately 1.2- to 1.5-fold higher
than the WT reference), the total level of priming of plus-strand DNA
was lower for all spliced forms, with the exception of Sp14 (Table 3).
Interestingly, Sommer et al. detected lower levels of Sp1 DNA in
extracellular virions when compared to full-length DNA (Sommer et
al., 2000). Because only capsids containing mature DNA are enveloped
(Gerelsaikhan et al., 1996), they postulated that the apparent decrease
in secretion of virions containing Sp1 DNA could be the result of lower
levels of plus-strand DNA (Sommer et al., 2000). Our results indicate
that synthesis of plus-strand DNA is inefﬁcient for Sp1.We predict that
capsids containing Sp14 DNA will be enveloped and secreted from
cells as efﬁciently as ones containing full-length DNA, unless the size
of the genome has an impact on envelopment.
Wewere able to abrogate levels of splicing by altering the common
splice acceptor site (Fig. 5A). The results in Fig. 5B shows that both
spliced RNA and DNA derived from spliced RNAs were no longer
detected and synthesis of DNA from the full-length template was
normal. This variant will be a useful tool to study the contribution of
cis-acting sequences and trans-acting factors to the synthesis of plus-
strand DNA synthesized from full-length minus-strand DNA.
Our work has shown that DNA derived from spliced RNA can
comprise up to one half of the replicative intermediates isolated from
intracellular capsids in both cell lines. These high levels were
inﬂuenced by the methods we used to engender DNA synthesis.
Although we detected ﬁve spliced RNAs in our cell cultures, other
spliced forms are likely to be present depending on HBV genotype
(Gunther et al., 1997; Sommer et al., 2000). Thus, DNA derived from
spliced RNA appears to be a consistent feature of HBV replication
independent of expression plasmid, genotype or cell line used.
Therefore, it is important to account for their presence when ana-
lyzing DNA replication in transfected cell cultures.
Materials and methods
Molecular clones
All molecular clones of HBV were derived from the subtype ayw
(GenBank accession number V01460). The C of the unique EcoRI site
(GAATTC) was designated nucleotide position 1. The molecular clone
for DHBV was derived from the strain DHBV3. The plasmid D1.5G
36 T.M. Abraham et al. / Virology 379 (2008) 30–37contains 1.5 copies of the DHBV genome and expresses the DHBV
pgRNA and all viral proteins (Habig and Loeb, 2002). Plasmids LJ144
and NL84 contain 1.1 copies of the HBV genome, and express the HBV
pgRNA under the transcriptional control of CMV-IE promoter and
derived from the parental clone pCH-9/3091 (Nassal, 1992). Plasmid
LJ144 does not express the envelope proteins (Haines and Loeb, 2007).
Plasmid NL84 is null for P, C, X and envelope protein synthesis (Liu et
al., 2004). A separate plasmid, LJ96, provides the proteins P, C and X, in
trans, but its RNA cannot be encapsidated (Liu et al., 2004). LJ96 was
derived from pCH-9/3142 (Junker-Niepmann et al., 1990). The plasmid
LJ140 contains 1.3 copies of the HBV genome. It expresses the HBV
pgRNA under the transcriptional control of the endogenous HBV
promoter but does not express any of the three envelope proteins due
to mutation. Plasmid EL49 was constructed by oligonucleotide-directed
mutagenesis and derived from plasmid NL84. EL49 has nts 484 to 487
changed from CAGG to GTCC. These changes disrupt the splice acceptor
site (Mount, 1982). Sp1, 3, 6, 14 and 18 plasmids express RNAs with the
authentic spliced junctions (Fig. 2). These plasmidswere created by PCR
ampliﬁcation of viral replicative intermediates isolated from Huh7 or
HepG2 cells using oligonucleotides ayw1816+, which has a sequence
complementary to the minus-strand from nt 1816 to 1858 on the
genome, and ayw1821−, which has a sequence complementary to the
plus-strand from nt 1797 to 1821 on the genome. The ampliﬁed DNA
fragments were cloned into the plasmid NL84. Splice junctions were
identiﬁed by DNA sequencing and classiﬁed according to the
nomenclature by Gunther et al. (1997).
Cell cultures and transfection
Chicken hepatoma cell line, LMH, was transfected with DHBV
plasmids. Culturing and transfection of LMH cells were performed as
described (Loeb and Tian, 1995). Human hepatoma cell lines, Huh7
and HepG2, were transfected with HBV plasmids. Culturing and
transfection of Huh7 and HepG2 cells were performed as described
(Liu et al., 2004).
Isolation of total cellular poly(A) RNA and encapsidated nucleic acid
Total cellular poly(A) RNA was isolated from Huh7 or HepG2 cells
as described (Loeb et al., 2002). Viral nucleic acid from cytoplasmic
capsids was isolated from LMH cells (Habig and Loeb, 2002) and Huh7
and HepG2 cells (Liu et al., 2004) as described.
Analysis of viral nucleic acid
One-third of the RNA isolated from a 60-mmplate transfected with
the plasmid LJ140, 1/10 of the RNA isolated from the plate transfected
with plasmid LJ144, and 1/6 of the RNA isolated from the plate
transfected with plasmids NL84 or EL49 was analyzed by northern
blotting as described (Loeb et al., 2002). These fractions represented
similar mass of pgRNA. pgRNA and spliced RNAs were detected using
an end-labeled oligonucleotide ayw2007– via hybridization of north-
ern blots. This probe does not detect sgRNAs. See Table 1 for the
nucleotide sequence of ayw2007−. One-half of the DNA extracted from
intracellular capsids from plates transfected with plasmid NL84 and 1/
6 of the DNA isolated from intracellular capsids isolated from cultures
transfected with plasmid LJ144 were analyzed by Southern blotting as
described (Lewellyn and Loeb, 2007). These fractions contained
similar masses of FL minus-strand DNA. Prior to electrophoresis,
replicative intermediates were treated with 2 mg of RNase A at 37 °C
for 30min. The samples were either untreated or heat denatured at 95
°C for 3 min and placed on ice for 5 min. Samples were
electrophoresed in a 1.25% agarose gel, and transferred to Hybond N
membrane. 32P-labeled oligonucleotide probes or 32P-labeled full-
length RNA probes were used to detect minus-strand DNA. 32P-labeled
oligonucleotides were used to detect plus-strand DNA. Membraneswere incubated at a speciﬁc annealing temperature for each oligo-
nucleotide for 4 hours, washed with Church wash buffer (1% SDS, 20
20 mM Na2HPO4 [pH 7.2], 1 mM EDTA [pH 8.0]) at room temperature,
and placed into phosphorimaging cassettes. Membranes were probed
sequentially for all minus-strand DNA, speciﬁc splice-derived minus-
strand DNA and all plus-strand DNA. Oligonucleotide probes were
removed from the membrane by incubating the membrane at 65 °C in
H2O for 30 min. Removal of oligonucleotide probes was veriﬁed by
autoradiography. See Table 1 for nucleotide sequence of oligonucleo-
tide probes.
Primer extension analysis with two oligonucleotides was used to
measure the levels of minus-strand DNA normalized to encapsidation
events for each spliced RNA as described (Abraham and Loeb, 2006).
Primer extension to measure the level of plus-strand priming from
DR2, circularization of plus-strands initiating from DR2 and plus-
strand priming from DR1 was performed as described (Lewellyn and
Loeb, 2007). Brieﬂy, 600 pg of a linearized plasmid was added to each
sample of capsid DNA as an internal standard. The DNA mixture was
heated to 95 °C for 5 min, treated with 1 mg of RNase A for 30 min at
37 °C, precipitated with ethanol, and resuspended in H2O. This sample
was split into three portions for primer extension analysis. To measure
levels of minus-strand DNA, oligonucleotide ayw1661+ with sequence
complementary to nt 1661 to 1685 was used. Extension from
oligonucleotide ayw1661+results in a 165 nt DNA fragment. Oligonu-
cleotide ayw1815− with sequence complementary to nt 1801 to 1815
was used to measure the level of plus-strand DNA that had primed
from DR2 and extended to at least nt 1815. Extension using ayw1815−
results in a 217 nt DNA fragment. Oligonucleotide ayw1948− with
sequence complementary to nt 1928 to 1948 was used to measure the
level of plus-strand DNA that had initiated from DR2 and extended to
at least nt 1948. This 350-nt product with ayw1948− represents plus-
strand DNA that had undergone circularization. Oligonucleotide 1948−
also measured the level of plus-strand DNA primed from DR1 (132 nt
DNA fragment). Sequencing ladders were generated using individual
oligonucleotides and HBV plasmid DNA as template, as described
(Habig and Loeb, 2002). Primer extension products were electro-
phoresed through a 5% denaturing polyacrylamide gel. The gels were
dried, placed into phosphorimaging cassettes, and scanned using
Molecular Dynamics Typhoon (model 8610).
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